reports
Vivendi : Information relative au nombre total de droits de vote et d’...
PARIS--(BUSINESS WIRE)-- Regulatory News: Vivendi (Paris:VIV): Place de cotation : NYSE Euronext-Paris Compartiment : Eurolist A Code ISIN : FR0000127771 Date Nombre total d’actions composant le capital social Nombre total de droits de vote 30 avril 2024 1 029 918 125 Total brut (1) de droits de vote : 1 060 971 005 Total net (2) de droits de vote : 1 046 091 029 (1) Total brut = après prise en compte du nombre d’actions bénéficiant du droit de vote double et du nombre d’actions auto-détenues au 30 avril 2024. (2) Total net = nombre ...
- Carole Braudeau
- Konrad Zomer
- Thomas Zlowodzki
LHA DEUTSCHE LUFTHANSA AG
MT ARCELORMITTAL SA
GALP GALP ENERGIA SGPS SA CLASS B
DBK DEUTSCHE BANK AG
FORTUM FORTUM OYJ
DAI DAIMLER AG
RXL REXEL SA
TEP TELEPERFORMANCE SE
WKL WOLTERS KLUWER NV
REE RED ELECTRICA CORP. SA
ORSTED ORSTED
GN GN STORE NORD A/S
VOW3 VOLKSWAGEN AG PREF
CAP CAPGEMINI SE
NEM NEMETSCHEK SE
RAA RATIONAL AG
AENA AENA SME SA
CABK CAIXABANK SA
WLN WORLDLINE SA
INGA ING GROEP NV
BBVA BANCO BILBAO VIZCAYA ARGENTARIA S.A.
STLA STELLANTIS N.V.
SHEL SHELL PLC
GSK GSK PLC
DSFIR KONINKLIJKE DSM N.V.
NOVO B NOVO NORDISK A/S
- Konrad Zomer
- Thomas Zlowodzki
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/02/2024
We are removing GALP from our ODDO BHF European Large Caps list. The stock has chalked up a performance of +31.3% since its inclusion in the list on 20 March. Our analyst is adopting today a Neutral recommendation (vs Outperform) on the stock. - ...
LHA DEUTSCHE LUFTHANSA AG
MT ARCELORMITTAL SA
GALP GALP ENERGIA SGPS SA CLASS B
DBK DEUTSCHE BANK AG
FORTUM FORTUM OYJ
DAI DAIMLER AG
RXL REXEL SA
TEP TELEPERFORMANCE SE
WKL WOLTERS KLUWER NV
REE RED ELECTRICA CORP. SA
ORSTED ORSTED
GN GN STORE NORD A/S
VOW3 VOLKSWAGEN AG PREF
CAP CAPGEMINI SE
NEM NEMETSCHEK SE
RAA RATIONAL AG
AENA AENA SME SA
CABK CAIXABANK SA
WLN WORLDLINE SA
INGA ING GROEP NV
BBVA BANCO BILBAO VIZCAYA ARGENTARIA S.A.
STLA STELLANTIS N.V.
SHEL SHELL PLC
GSK GSK PLC
DSFIR KONINKLIJKE DSM N.V.
NOVO B NOVO NORDISK A/S
- Carole Braudeau
- ING Helpdesk
Benelux Morning Notes
Aedifica: First sign of portfolio valuation stabilization. ArcelorMittal: Solid 1Q24 EBITDA beat, softer FCF reflects WC and CAPEX phasing. Belgian telcos: Peer Telenet 1Q24 results, still weak commercial performance. dsm-firmenich AG: Vita-still not-min. IBA: Contract to install a P1 system in Connecticut. KPN: VodafoneZiggo 1Q24 results confirm fixed losses, mobile weaker QoQ. Shell plc: Good start to the year
- Emna Ben Bdira
- Maxime Kogge
ArcelorMittal : Sound Q1 driven by NorthAm and Brazil, Europe and Mini...
>Solid Q1 thanks to NorthAm and Brazil, Europe and Mining more subdued - ArcelorMittal just released solid Q1 results with EBITDA of $ 1.96bn, 9% above the consensus and 4% above ODDO BHF. The beat was mostly driven by good price and cost development while volumes were broadly in line. EBITDA improved 35% q-o-q thanks to seasonally higher volumes and higher prices but slid 9% y-o-y as 2023 had seen even stronger prices and volumes. Net income was a stronger beat at $ ...
- Emna Ben Bdira
- Maxime Kogge
ArcelorMittal : Sound Q1 driven by NorthAm and Brazil, Europe and Mini...
>Solid Q1 thanks to NorthAm and Brazil, Europe and Mining more subdued - ArcelorMittal just released solid Q1 results with EBITDA of $ 1.96bn, 9% above the consensus and 4% above ODDO BHF. The beat was mostly driven by good price and cost development while volumes were broadly in line. EBITDA improved 35% q-o-q thanks to seasonally higher volumes and higher prices but slid 9% y-o-y as 2023 had seen even stronger prices and volumes. Net income was a stronger beat at $ ...
Press Release: Beyfortus real-world evidence published in The Lancet s...
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the 2023-2024 RSV season, versus no intervention1-6Results add to the consistent high efficacy of Beyfortus against medically attended RSV lower respiratory tract disease, shown in the pivotal clinical studies and the o...
Communiqué de presse : Des données de vie réelle concernant Beyfortus ...
Communiqué de presse : Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS De nouvelles données de vie réelle montrent que Beyfortus (nirsevimab) a permis de réduire sensiblement les infections des voies respiratoires inférieures dues au VRS chez les nourrissons, de même que les hospitalisations, au cours de la saison virale 2023-2024, compa...
ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results
ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results Luxembourg, May 2, 2024 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for the three-month period ended March 31, 2024. 1Q 2024 key highlights: Health and safety focus: Protecting employee health and wellbeing remains the overarching priority of the Company; the Company-wide audit of safety by dss+ is progressing and will support our p...
Assa Abloy AB: 1 director
A director at Assa Abloy AB bought 5,000 shares at 298.530SEK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Sanofi: 1 director
A director at Sanofi bought 1,000 shares at 91.380EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
ArcelorMittal announces results of its General Meeting
ArcelorMittal announces results of its General Meeting 30 April 2024, 18:15 CET The Annual General Meeting (‘General Meeting’) of shareholders of ArcelorMittal held today in Luxembourg approved all resolutions by a strong majority. 78.47% of the voting rights were represented at the General Meeting. The results of the votes will be posted shortly on under ‘Investors – Equity investors – Shareholders events – AGM – Annual General Meeting of shareholders, 30 April 2024’ where the full documentation regarding the General Meeting is available. In particular, the shareholders: Approved the ...
Press Release: Annual General Meeting of April 30, 2024
Press Release: Annual General Meeting of April 30, 2024 Annual General Meeting of April 30, 2024 Approval of the financial statements for the fiscal year 2023Distribution of a cash dividend of €3.76 per share, with payment as of May 15, 2024Board composition: renewal of two Directors and appointment of three new Independent Directors Paris, April 30, 2024. The Combined General Shareholders’ Meeting of Sanofi was held on April 30, 2024, under the chairmanship of Frédéric Oudéa. All resolutions submitted to the vote were adopted by the shareholders. The General Meeting approved the indi...
Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2024
Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2024 Assemblée Générale Annuelle du 30 avril 2024 Approbation des comptes sociaux et des comptes consolidés de l’exercice 2023Distribution d’un dividende en numéraire de 3,76 euros par action, dont la mise en paiement interviendra le 15 mai 2024Composition du Conseil d’administration : renouvellement de deux administrateurs et nomination de trois nouveaux administrateurs indépendants Paris, le 30 avril 2024. L’Assemblée Générale Mixte des actionnaires de Sanofi s’est réunie le 30 avril 2024, sous la présidence de Frédéric ...
Vivendi : Descriptif du programme de rachat d’actions autorisé par l’A...
PARIS--(BUSINESS WIRE)-- Regulatory News: Vivendi (Paris:VIV): Le présent descriptif est établi en application des dispositions des articles 241-1 et 241-2 du Règlement général de l’Autorité des marchés financiers. 1. Date de l’Assemblée générale ayant autorisé le programme de rachat d’actions et de mise en œuvre. L’autorisation d’achat par la société de ses propres actions a été donnée par l’Assemblée générale mixte du 29 avril 2024 (vingt-et-unième résolution). Elle est mise en œuvre sur délégation du Directoire du 29 avril 2024. 2. Nombre de titres et part du capital détenu direct...
Vivendi : l’Assemblée générale annuelle 2024 approuve l’ensemble des r...
PARIS--(BUSINESS WIRE)-- Regulatory News: Vivendi (Paris:VIV) : L’Assemblée générale mixte annuelle des actionnaires de Vivendi s’est tenue aujourd’hui à L’Olympia à Paris sous la présidence de Yannick Bolloré avec un quorum de 70,15 % d’actionnaires présents ou représentés. L’Assemblée a approuvé l’ensemble des 25 résolutions qui lui étaient présentées à titre ordinaire et à titre extraordinaire (requérant une majorité des deux tiers). Les actionnaires ont renouvelé pour un terme de quatre ans les mandats de membre du Conseil de surveillance de Yannick Bolloré et Laurent Dassault. A l...
- Bruno Cavalier
- Jerôme Bodin
MC LVMH MOET HENNESSY LOUIS VUITTON SE
RI PERNOD RICARD SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EL ESSILORLUXOTTICA SA
AMUN AMUNDI SA
VIV VIVENDI SE
PHIA KONINKLIJKE PHILIPS N.V.
BRBY BURBERRY GROUP PLC
KER KERING SA
SAF SAFRAN S.A.
BOL BOLLORE SA
01913 PRADA S.P.A.
MONC MONCLER SPA
MAP MAPFRE SA
SKF B SKF AB CLASS B
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
LIVS AUTOLIV INC. SDR
DHER DELIVERY HERO SE
STM STMICROELECTRONICS NV
DWS DWS GROUP GMBH & CO. KGAA
UMI UMICORE
8TRA TRATON SE
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
SGSN SGS SA
TEN TENARIS S.A.
- Jerôme Bodin
ODDO : Q1 revenue for Vivendi and Bolloré in line, with a solid perfor...
>Q1 in line but no new information on the spin-off plan - This morning, Vivendi and Bolloré published their Q1 revenues, to be followed by a conference call. However, Vivendi is to hold its AGM this morning at 10.00 a.m. Revenues were in line with our expectations. We have consolidated these two publications whilst the bulk of Bolloré's revenue (73%) now hinges on Vivendi since the deconsolidation of Bolloré logistics. Vivendi's Q1 revenue was in line with our forecas...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.